Indazole compounds and pharmaceutical compositions for...

Details Indazole compounds and pharmaceutical compositions for... Indazole compounds and pharmaceutical compositions for...

2005-04-26

2005-04-26

Davis, Zinna Northington (Department: 1625)

Organic compounds -- part of the class 532-570 series

Organic compounds

Heterocyclic carbon compounds containing a hetero ring...

C548S362500

Reexamination Certificate

active

06884890

ABSTRACT:
Indazole compounds that modulate and/or inhibit the activity of certain protein kinases are described. These compounds and pharmaceutical compositions containing them are capable of mediating tyrosine kinase signal transduction and thereby modulate and/or inhibit unwanted cell proliferation. The invention is also directed to the therapeutic or prophylactic use of pharmaceutical compositions containing such compounds, and to methods of treating cancer and other disease states associated with unwanted angiogenesis and/or cellular proliferation, such as diabetic retinopathy, neovascular glaucoma, rheumatoid arthritis, and psoriasis, by administering effective amounts of such compounds.

REFERENCES:
patent: 5621082 (1997-04-01), Xiong et al.
patent: 5705499 (1998-01-01), Cywin et al.
patent: 5760028 (1998-06-01), Jadhav et al.
patent: 5861414 (1999-01-01), Allen et al.
patent: 5886195 (1999-03-01), Tang et al.
patent: DD 273 062 (1989-11-01), None
patent: 0 066 270 (1982-08-01), None
patent: 0 816 357 (1998-01-01), None
patent: WO 8605779 (1986-10-01), None
patent: WO 9319052 (1993-09-01), None
patent: WO 9614843 (1996-05-01), None
patent: WO 9623783 (1996-08-01), None
patent: WO 9703967 (1997-02-01), None
patent: WO 9716447 (1997-05-01), None
patent: WO 9734876 (1997-09-01), None
patent: WO 9748697 (1997-12-01), None
patent: WO 9809961 (1998-03-01), None
patent: WO 98144851 (1998-04-01), None
patent: WO 9921845 (1999-05-01), None
patent: WO 9923076 (1999-05-01), None
patent: WO 9923077 (1999-05-01), None
patent: WO 0018761 (2000-04-01), None
Al-Khodairy et al.,Molec. Biol. Cell, 5, 147-160 (1994).
Alon et al,Nat. Med., 1, 1024 (1995).
Bolen,Oncogene, 8, 2025-2031 (1993).
Bunz et al.,Science, 282, 1497 (1998).
Castro et al.,J. Med Chem, 39:842-849 (1996).
Cohen,Curr. Op. Chem. Biol., 3, 459-65 (1999).
Folkman,Nature Med., 1, 27-31 (1995).
Hartwell et al.,Science, 266, 1821-1828 (1994).
Hartwell et al.,Science, 246, 629-634 (1989).
Holash et al.,Oncogene, 18, 5356-62 (1999).
Jeffrey et al.,Nature, 376, 313-320 (Jul. 27, 1995).
Kamb,Trends in Genetics, 11, 136-140 (1995).
Kamb et al.,Science, 264, 436-440 (1994).
Katsura et al.,Chem Pharm Biol, 40(8), 2062-2074-140 (1992).
Klohs et al.,Curr. Op. Chem. Biol., 10, 544-49 (1999).
Klunder et al.,J. Med. Chem, 41, 2960-2971 (1998).
Lee et al.,Biochem, 23, 4255 (1984).
Lin et al.,J Med Chem., 15(6), 615 (1972).
Lutty and McLeod,Arch. Ophthalmol., 110, 267 (1992.
Maisonpierre et al.,Science, 277, 55-60 (1997).
Matsuoka,Science, 282, 1893-1897 (1998).
McMahon et al.,Current Opinion in Drug Discovery&Development, 1, 131-146 (1998).
McMahon et al,Oncologist, 5, 3-10 (2000).
Merenmines et al.,Cell Growth&Differentiation, 8, 3-10 (1997).
Millauer et al.,Cancer Research, 56, 1615-1620 (1996).
Mohammadi et al.,EMBO Journal, 17, 5896-5904 (1998.
Mohammadi et al.,Mol. Cell. Biol., 16, 977-989 (1996).
Mylari et al.,J. Med. Chem., 35, 457-465 (1992).
Nurse,Cell, 91, 865-867 (1997).
O'Connor,Cancer Surveys, 29, 151-182 (1997).
Parast et al.,BioChemistry, 37, 16788-16801 (1998).
Peng et al.,Science, 277, 1501-1505 (1997).
Penn et al,Invest. Ophthalmol. Vis. Sci., 36, 2063, (1995).
Rosenblatt et al.,J. Mol. Biol., 230, 1317-1319 (1993).
Rosowsky et al,J. Med Chem., 31, 763-768 (1988).
Sanchez et al.,Science, 277, 1497-1501 (1997).
Sarodnick et al,J. Prakt Chem. 339. 714-720 (1997).
Still et al.,J. Org. Chem., 43, 2923 (1978).
Stone et al,J. Neurosci., 15, 4738 (1995).
Strawn et al.,Exp. Opin. Invest. Drugs, 7, 553-573 (1998).
Thomas et al.,J. Biol. Chem., 274, 36684-92 (1999).
Thompson,Oncogene, 15, 3025-3035 (1997).
Walworth et al.,Nature, 363, 368-371 (1993).
Weinert,Science, 277, 1450-1451 (1997).
Whitney et al., DNA Cell Biol 9, 823-830, 1993.
Winters et al.,Oncogene, 17, 673-684 (1998).
Yoshiji et al.,Cancer Research, 57, 3924-3928 (1997).
Zeng et al.,Nature, 395, 504-510 (1998).

Affiliated with

Also associated with

Rating

Indazole compounds and pharmaceutical compositions for... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Indazole compounds and pharmaceutical compositions for..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Indazole compounds and pharmaceutical compositions for... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3371698